Growth Metrics

Cumberland Pharmaceuticals (CPIX) Other Non-Current Liabilities (2016 - 2026)

Cumberland Pharmaceuticals' Other Non-Current Liabilities history spans 16 years, with the latest figure at $5.8 million for Q4 2025.

  • On a quarterly basis, Other Non-Current Liabilities fell 7.58% to $5.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $5.8 million, a 7.58% decrease, with the full-year FY2025 number at $5.8 million, down 7.58% from a year prior.
  • Other Non-Current Liabilities hit $5.8 million in Q4 2025 for Cumberland Pharmaceuticals, down from $6.0 million in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for CPIX hit a ceiling of $11.3 million in Q1 2022 and a floor of $5.8 million in Q4 2025.
  • Historically, Other Non-Current Liabilities has averaged $7.3 million across 5 years, with a median of $6.8 million in 2023.
  • Biggest five-year swings in Other Non-Current Liabilities: soared 44.56% in 2022 and later crashed 37.38% in 2023.
  • Tracing CPIX's Other Non-Current Liabilities over 5 years: stood at $7.5 million in 2021, then increased by 1.28% to $7.6 million in 2022, then decreased by 14.92% to $6.5 million in 2023, then dropped by 2.38% to $6.3 million in 2024, then fell by 7.58% to $5.8 million in 2025.
  • Business Quant data shows Other Non-Current Liabilities for CPIX at $5.8 million in Q4 2025, $6.0 million in Q3 2025, and $6.3 million in Q2 2025.